Showing results (1-10 of 3) with videos related to
Sort By:
Pageof 1
Molecular and Clinical Oncology|May 17, 2024
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expressionMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.Anticancer Research|February 29, 2024
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet ChemotherapyMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.In Vivo (Athens, Greece)|April 30, 2024
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case ReportTakahiro Hirai, Minehiko Inomata, Shuhei Minatoyama, et al.Pageof 1